Total debt fell to $231.6M in 3Q26 from $797.9M a year earlier, cutting debt-to-equity to 0.66, yet an accumulated deficit near -$1.4B and a current ratio that compressed from 6.46 to 2.49 suggest the deleveraging warrants scrutiny of its durability.
Novocure Ltd (NVCR) balance sheet — 13-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|
| Total Current Assets | 673.52M | 646.73M | 1.11B | 1.03B | 1.11B | 1.07B | 999.44M | 439.95M | 321.37M | 245.13M | 261.87M | 293.9M | 111.83M | 183.48M |
| Cash & Short-Term Investments | 463.48M | 457.52M | 959.87M | 910.62M | 969.42M | 938.51M | 854.08M | 328.19M | 245.88M | 183.31M | 219.63M | 269.42M | 102.61M | 175.89M |
| Cash Only | 96.73M | 103.39M | 163.77M | 240.82M | 115.33M | 209.61M | 246.17M | 179.42M | 140.62M | 78.59M | 99.78M | 119.42M | 57.61M | 175.89M |
| Short-Term Investments | 366.75M | 354.13M | 796.11M | 669.79M | 854.1M | 728.9M | 607.9M | 148.77M | 105.26M | 104.72M | 119.85M | 150M | 45M | 0 |
| Accounts Receivable | 108.26M | 115.35M | 102.07M | 77.11M | 106.03M | 97.41M | 100.47M | 63.96M | 36.52M | 29.57M | 6.34M | 0 | 0 | 3.88M |
| Days Sales Outstanding | 58.21 | 64.24 | 61.56 | 55.26 | 71.95 | 66.45 | 74.18 | 66.45 | 53.74 | 60.96 | 27.91 | - | - | 136.75 |
| Inventory | 40.6M | 41.11M | 35.09M | 38.15M | 29.38M | 24.43M | 27.42M | 23.7M | 22.55M | 22.02M | 25.55M | 13.59M | 3.45M | 1.89M |
| Days Inventory Outstanding | 91.62 | 89.92 | 93.35 | 108.56 | 93.34 | 77.61 | 93.98 | 97.63 | 102.85 | 144.57 | 201.49 | 240.75 | 125.33 | 98.47 |
| Other Current Assets | 61.17M | 23.1M | 2.33M | 1.74M | 508K | 8.47M | 13.51M | 21.85M | 2.13M | 2.13M | 267K | 9.37M | 4.82M | 970K |
| Total Non-Current Assets | 155.19M | 157.59M | 134.21M | 111.72M | 80.12M | 65.97M | 52.54M | 39.5M | 18.42M | 20.16M | 20.21M | 13.43M | 6.05M | 5.43M |
| Property, Plant & Equipment | 144.09M | 147M | 119.59M | 97.7M | 68.96M | 53.88M | 41.63M | 34.6M | 15.37M | 18.07M | 18.62M | 12.58M | 5.75M | 5.18M |
| Fixed Asset Turnover | 4.99x | 4.46x | 5.06x | 5.21x | 7.80x | 9.93x | 11.87x | 10.15x | 16.14x | 9.80x | 4.45x | 2.63x | 2.69x | 2.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11.1M | 10.6M | 14.62M | 14.02M | 11.16M | 12.09M | 10.91M | 4.9M | 3.06M | 2.1M | 1.59M | 851K | 297K | 252K |
| Total Assets | 828.71M | 804.33M | 1.24B | 1.15B | 1.19B | 1.14B | 1.05B | 479.45M | 339.79M | 265.3M | 282.08M | 307.34M | 117.88M | 188.91M |
| Asset Turnover | 0.90x | 0.81x | 0.49x | 0.44x | 0.45x | 0.47x | 0.47x | 0.73x | 0.73x | 0.67x | 0.29x | 0.11x | 0.13x | 0.05x |
| Asset Growth % | -147.37% | -35.18% | 8.26% | -3.82% | 4.58% | 8.32% | 119.42% | 41.1% | 28.08% | -5.95% | -8.22% | 160.73% | -37.6% | - |
| Total Current Liabilities | 270.66M | 223.23M | 756.38M | 179.12M | 158.78M | 142.6M | 113.61M | 86.31M | 64.56M | 50.2M | 36.88M | 28.63M | 17.67M | 15.6M |
| Accounts Payable | 145.92M | 122.23M | 105.09M | 94.39M | 85.2M | 72.6M | 53.65M | 36.92M | 26.71M | 17.21M | 18.36M | 13.9M | 10.03M | 10.29M |
| Days Payables Outstanding | 287.96 | 267.35 | 279.6 | 268.57 | 270.72 | 230.67 | 183.86 | 152.11 | 121.78 | 112.93 | 144.76 | 246.26 | 364.89 | 535.35 |
| Short-Term Debt | 25M | 11.66M | 558.16M | 0 | 0 | 6.68M | 6.48M | 4.63M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 15.95M | 14.22M | 16.22M | 18.03M | 17.76M | 17.77M | 11.77M | 8.84M | 4.96M | 2.27M | 0 | 0 | 0 |
| Other Current Liabilities | 99.74M | 9.03M | 0 | 0 | 0 | 169K | 61K | 64K | 12.26M | 5.64M | 5.58M | 3.61M | 1.79M | 445K |
| Current Ratio | 2.49x | 2.90x | 1.46x | 5.78x | 7.00x | 7.53x | 8.80x | 5.10x | 4.98x | 4.88x | 7.10x | 10.27x | 6.33x | 11.76x |
| Quick Ratio | 2.34x | 2.71x | 1.42x | 5.56x | 6.82x | 7.36x | 8.56x | 4.82x | 4.63x | 4.44x | 6.41x | 9.79x | 6.13x | 11.64x |
| Cash Conversion Cycle | -138.13 | -113.18 | -124.69 | -104.76 | -105.42 | -86.61 | -15.7 | 11.97 | 34.8 | 92.59 | 84.64 | - | - | -300.13 |
| Total Non-Current Liabilities | 207.44M | 240.63M | 124.23M | 604.52M | 591.7M | 586.4M | 461.85M | 175.35M | 162.97M | 101.53M | 102.85M | 27.89M | 2.33M | 1.53M |
| Long-Term Debt | 171.34M | 236.69M | 97.3M | 568.82M | 565.51M | 562.22M | 429.9M | 149.42M | 149.27M | 97.34M | 96.23M | 23.1M | 321K | 346K |
| Capital Lease Obligations | 153.87M | 41.65M | 19.97M | 27.42M | 18.76M | 13M | 14.29M | 14.14M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 124K | 0 | -906K | -785K | 0 | 0 |
| Other Non-Current Liabilities | 882K | -37.71M | 6.96M | 8.28M | 4.55M | 4.71M | 5.51M | 3.98M | 3.65M | 4.19M | 6.62M | 4.79M | 2.01M | 1.19M |
| Total Liabilities | 478.1M | 463.86M | 880.61M | 783.63M | 750.48M | 729M | 575.46M | 261.66M | 227.53M | 151.73M | 139.74M | 56.52M | 20M | 17.13M |
| Total Debt | 231.55M | 290M | 683.35M | 596.24M | 584.27M | 581.9M | 450.68M | 168.2M | 149.27M | 97.34M | 96.23M | 23.1M | 321K | 346K |
| Net Debt | 134.82M | 186.61M | 519.59M | 355.42M | 468.94M | 372.29M | 204.51M | -11.22M | 8.65M | 18.75M | -3.55M | -96.33M | -57.29M | -175.55M |
| Debt / Equity | 0.66x | 0.85x | 1.90x | 1.64x | 1.32x | 1.42x | 0.95x | 0.77x | 1.33x | 0.86x | 0.68x | 0.09x | 0.00x | 0.00x |
| Debt / EBITDA | -2.15x | - | - | - | - | - | 11.39x | 22.29x | - | - | - | - | - | - |
| Net Debt / EBITDA | -1.25x | - | - | - | - | - | 5.17x | -1.49x | - | - | - | - | - | - |
| Interest Coverage | -15.27x | - | -10.36x | -38.41x | -9.68x | -5.50x | 1.98x | 0.34x | -1.92x | -3.15x | -16.55x | -36.22x | -438.57x | -5.08x |
| Total Equity | 350.61M | 340.47M | 360.18M | 362.5M | 441.17M | 410.49M | 476.53M | 217.79M | 112.26M | 113.56M | 142.34M | 250.82M | 97.88M | 171.78M |
| Equity Growth % | -14.63% | -5.47% | -0.64% | -17.83% | 7.47% | -13.86% | 118.8% | 94.01% | -1.15% | -20.22% | -43.25% | 156.27% | -43.02% | - |
| Book Value per Share | 3.00 | 3.05 | 3.34 | 3.41 | 4.22 | 3.97 | 4.38 | 2.24 | 1.22 | 1.28 | 1.66 | 3.00 | 1.36 | 14.27 |
| Total Shareholders' Equity | 350.61M | 340.47M | 360.18M | 362.5M | 441.17M | 410.49M | 476.53M | 217.79M | 112.26M | 113.56M | 142.34M | 250.82M | 97.88M | 171.78M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -1.39B | -1.29B | -1.15B | -985.5M | -778.46M | -685.93M | -631.08M | -650.88M | -643.65M | -582.26M | -519.93M | -388.08M | -276.5M | -195.82M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.59M | -3.44M | -5.5M | -5.47M | -2.43M | -3.17M | -3.83M | -2.77M | -1.4M | -1.34M | -1.88M | -1.5M | -4.28M | -2.41M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying NVCR stock.
As of 2025, Novocure Ltd (NVCR) had total assets of $804.3M including $646.7M in current assets.
Novocure Ltd (NVCR) carries total debt of $290.0M, offset by $457.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Novocure Ltd (NVCR) has total shareholders' equity (book value) of $340.5M ($3.05 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Novocure Ltd (NVCR) reported a current ratio of 2.90x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage reliant on debt refinancing
Metrics are mathematically derived from official filings.
Deleveraging Driven by Debt Reduction
Based on NVCR's reported figures, total debt fell from $797.9M in 3Q25 to $231.6M in 3Q26, lowering the debt-to-equity ratio from 2.34 to 0.66 and marking a sharp shift in the balance sheet structure over the period.
The reduction appears to have been driven primarily by debt retirement rather than by equity growth, since shareholders' equity remained within a narrow band of roughly $330M to $362M across all ten quarters. Total liabilities fell alongside debt, which suggests the deleveraging is genuine rather than a reclassification, though the reported figures alone do not reveal how the repayment was funded. Investors should monitor whether the cash position of $96.7M is sufficient to sustain operations if the company continues to post net losses.
Debt Concentration Shifted Toward Lower Leverage
As reported in financial statements, NVCR's debt-to-assets ratio compressed from roughly 0.69 in 3Q25 to about 0.28 in 3Q26, indicating that the company's dependence on borrowed capital has declined materially within the most recent four quarters.
The pattern points to a leverage profile that moved from a potentially strained position toward one that appears more manageable on a reported basis. However, the persistent net losses across every reported quarter mean that debt service must still be met from a cash base that has fluctuated between roughly $93M and $345M. Refinancing risk cannot be fully assessed from these figures, and the maturity profile of remaining obligations warrants further investigation.
Current Ratio Compression Signals Tighter Buffers
Based on NVCR's reported figures, the current ratio declined from 6.46 in 2Q24 to 2.49 in 3Q26, while cash on hand has hovered near $94M to $103M in recent quarters, leaving a narrower buffer than the headline ratio implies.
The current ratio remains well above 1.0, which suggests near-term obligations are covered, but the decline from elevated levels indicates that current liabilities have grown relative to liquid assets over time. Cash holdings have stabilized in a relatively narrow range despite the company's ongoing operating losses, which may point to reliance on operating cash inflows or periodic financing. Investors should watch whether liquidity holds if quarterly revenue growth fails to offset the persistent operating deficit.
Accumulated Deficit Dwarfs Contributed Equity
As reported in financial statements, NVCR carries retained earnings of roughly -$1.4B against total equity of $350.6M, indicating that the cumulative losses absorbed the bulk of paid-in capital over the reporting window.
The gap between the accumulated deficit and equity suggests that equity value rests largely on contributed capital rather than retained profitability, a structure typical of companies still in a growth or clinical-expansion phase. Equity has remained stable at roughly $330M to $360M over ten quarters, implying that losses have been offset by new capital or stock-based issuance rather than eroding the base. Stock-based compensation may be contributing to dilution, a dynamic that warrants monitoring given the scale of the accumulated deficit.
Reported Deleveraging May Mask Refinancing Dependence
Based on reported figures, the sharp fall in debt between 3Q25 and 4Q25 coincided with a cash balance that did not rise commensurately, raising questions about how repayment was financed and whether the apparent balance sheet improvement is fully durable.
Headline leverage metrics have improved substantially, but the reported data does not disclose the source of funds used to retire roughly $500M of debt within two quarters. Cash balances remained near $100M, so the repayment may have relied on undisclosed financing, asset sales, or restructured terms that the supplied data does not capture. Given persistent net losses in every reported quarter, the durability of the improved leverage position cannot be confirmed without further review of the debt agreements and cash flow statements.